title: Busulphan is safe and efficient treatment in elderly patients with essential thrombocythemia.
authors.forename: L
authors.initials: L
authors.lastname: Shvidel
authors.forename: E
authors.initials: E
authors.lastname: Sigler
authors.forename: M
authors.initials: M
authors.lastname: Haran
authors.forename: A
authors.initials: A
authors.lastname: Klepfish
authors.forename: A
authors.initials: A
authors.lastname: Duek
authors.forename: A
authors.initials: A
authors.lastname: Berrebi
authors.forename: M
authors.initials: M
authors.lastname: Shtalrid
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D018906:Antineoplastic Agents, Alkylating / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002066:Busulfan / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D013920:Thrombocythemia, Essential / Q000188:drug therapy*; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D018906:Antineoplastic Agents, Alkylating; D002066:Busulfan